Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Quick facts
Phase 3 pipeline
- WPV01 · Infectious Diseases
WPV01 is a small molecule drug that targets the SARS-CoV-2 main protease.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Westlake Pharmaceuticals (Hangzhou) Co., Ltd. portfolio CI brief
- Westlake Pharmaceuticals (Hangzhou) Co., Ltd. pipeline updates RSS
Frequently asked questions about Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
What is Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s pipeline?
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 5 in Phase 1. Late-stage candidates include WPV01.
Related
- Sector hub: All tracked pharma companies